IHH Healthcare Bhd (XKLS:5225)

Q1 2026 IHH Healthcare Bhd Earnings Call Transcript

May 26, 2026 / 10:59 AM GMT

Release Date Price: RM8.98 (+0.22%)

Transcript

Key Points

Positve

IHH Healthcare Bhd (IHHHF) reported a 16% growth in revenue and EBITDA on a constant currency basis, showcasing strong performance across its diversified portfolio.
The company recorded strong performances in Malaysia, India, and Turkey, driven by higher inpatient volumes and revenue intensity while maintaining strict cost discipline.
IHH Healthcare Bhd (IHHHF) is on track to achieve a double-digit ROE by 2028, supported by strategic priorities, cost discipline, and transformation efforts.
The company is expanding its daycare and ambulatory care centers (ACCs), which are value-accretive and do not require significant capital investment.
IHH Healthcare Bhd (IHHHF) is actively pursuing medical tourism, with significant contributions from foreign patients in Malaysia and Turkey, and is exploring new markets such as Cambodia and the Philippines.

Negative

Singapore's performance is facing challenges due to a structural shift towards public healthcare consumption and external factors like Middle East tensions and currency depreciation.
The tax rate for the quarter increased to above 30% due to a one-off tax debit related to the Achibadam business, impacting overall financial performance.
FX volatility has been a drag on earnings, with translation impacts eroding reported growth figures despite strong operational performance.
The company is facing cost pressures for drugs and consumables due to the Middle Eastern crisis, which may lead to higher procurement costs.
IHH Healthcare Bhd (IHHHF) is experiencing a slowdown in patient footfall in Singapore due to new Integrated Shield Plan requirements, impacting recovery timelines.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IHHH.KL - IHH Healthcare Bhd
Q1 2026 IHH Healthcare Bhd Earnings Call
May 26, 2026 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to IGH Healthcare Berhad's Q1 2026 Analyst Bridging.

Thank you for taking the time to join us today given it is the eve of Hari Raya Haji and we do apologize for the delay as we were waiting for the results to be uploaded. My name is Kelvin from the IR team and joining me on the call today Dr. Prem Kumar Nai, Group CEO, Mr. Dilip Kadambi, Group CFO, Mr. Ashok Pandit, our Group CCO.

Very warm welcome to all. Today's session will begin with Dr. Pram sharing opening remarks for the quarter, followed by Dilip who will walk us through the financial highlights for Q1 2026. Arshad will then cover key operational updates across the group, after which we will open the floor for Q&A session. Dr. Pram, over to you please.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.